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Distinct B cell populations, designated regulatory B
(Breg) cells, are known to restrain immune responses
associated with autoimmune diseases. Additionally,
obesity is known to induce local inflammation within
adipose tissue that contributes to systemic meta-
bolic abnormalities, but the underlying mechanisms
that modulate adipose inflammation remain poorly
understood. We identified Breg cells that produce
interleukin-10 constitutively within adipose tissue. B
cell-specific Il10 deletion enhanced adipose inflam-
mation and insulin resistance in diet-induced obese
mice, whereas adoptive transfer of adipose tissue
Breg cells ameliorated those effects. Adipose envi-
ronmental factors, including CXCL12 and free fatty
acids, support Breg cell function, andBreg cell fraction
and function were reduced in adipose tissue from
obese mice and humans. Our findings indicate that
adipose tissue Breg cells are a naturally occurring
regulatory B cell subset that maintains homeostasis
within adipose tissue and that Breg cell dysfunction
contributes pivotally to the progression of adipose
tissue inflammation in obesity.
INTRODUCTION
Recent findings have shown that in addition to their capacity to
produce antibodies, distinct B cell subsets, the regulatory B
(Breg) cells, can restrain the excessive and pathological inflam-
matory responses that occur during autoimmune diseases
(Lemoine et al., 2009). This property of Breg cells is mainly
attributable to their secretion of interleukin-10 (IL-10) and/or
transforming growth factor beta (TGF-b), which inhibit proinflam-
matory cellular processes. Several phenotypically distinct sub-Cell Msets of B cells, including splenic B-1a, marginal zone (MZ) B
and transitional-2 (T2) MZ precursor B cells, as well as peritoneal
B-1 cells, are capable of producing IL-10 upon stimulation and
of negatively regulating inflammatory processes (DiLillo et al.,
2010; Vitale et al., 2010). B10 cells are one of the best-character-
ized regulatory B cells. They are a rare subset in lymphoid tissue
and bone marrow (BM), and suppress inflammatory responses
in an antigen-dependent manner via IL-10 (DiLillo et al., 2010).
However, only 1%–2% of splenic B cells are capable of pro-
ducing IL-10 upon stimulation (IL-10 competent), and they do
not constitutively produce IL-10.
Recent studies have shown that obesity induces chronic
inflammation within adipose tissue, which in turn leads to meta-
bolic abnormalities and inflammation in distant tissues. Macro-
phages and T cells play crucial roles in adipose inflammation
(Donath and Shoelson, 2011). In lean healthy adipose tissue,
inflammatory processes appear to be restricted. However,
feeding a high-fat diet (HFD) to mice quickly activates CD8+
T cells, which then promote macrophage accumulation and
their M1 activation, thereby triggering an inflammatory cascade
within visceral adipose tissue (Nishimura et al., 2009). By
contrast, CD4+ TH2 and regulatory T (Treg) cells, as well as
resident M2 macrophages, have been shown to suppress
inflammation within adipose tissue. Accordingly, it appears
that the balance among immune cells is important for the main-
tenance of homeostasis and control of inflammatory processes
within adipose tissue (Lumeng et al., 2009). However, the mech-
anisms by which the immune cell network controls adipose
tissue inflammation are poorly understood. Recently, Winer
et al. (2011) reported that adipose B cells secrete autoreactive
immunoglobulin G (IgG), which contributes to adipose inflam-
mation. However, it remains unknown whether there are Breg
cells present within adipose tissue, or other metabolic organs,
and whether they have a regulatory function there. Herein,
we describe a subset of Breg cells that are abundant within
adipose tissue and constitutively produce IL-10, with which
they restrain adipose tissue inflammation and maintain meta-
bolic homeostasis.etabolism 18, 759–766, November 5, 2013 ª2013 Elsevier Inc. 759
Figure 1. B Cells Constitutively Expressing
IL-10 Are Abundant in Adipose Tissue
(A) Flow cytometric analysis of CD19+ CD45R+ B
cells in the SV fraction (SVF) from epididymal,
inguinal s.c. (SC), retroperitoneal, and omental fat
pads from 20-week-old lean wild-type mice fed a
normal chow diet (ND). Flow cytometric plots
are representative of at least three independent
experiments throughout this paper.
(B) Intracellular IL-10 levels in CD19+ CD22+
CD45R+ B cells from adipose tissue and spleen
from 25-week-old wild-type (WT), diet-induced
obese (DIO), and Il10/ (IL-10KO) mice. Il10
knockout (IL-10KO) mice were used as a negative
control. Note that isolated B cells were un-
stimulated and directly used to analyze IL-10.
(C) Intracellular IL-10 levels in CD4+ Foxp3+ Treg
cells and F4/80+ CD11c CD206+ M2 macro-
phages from epididymal (red line) and inguinal s.c.
(blue line) adipose tissue from 20-week-old lean
mice. Black lines indicate the isotype-matched
negative control (NC).
(D) Levels of Il10 expression in the indicated cell
types in epididymal and s.c. fat from lean control
mice. Shown are levels in M1 (F4/80+ CD11c+
CD206) and M2 (F4/80+ CD11c CD206+) mac-
rophages, B cells (CD19+ CD22+ CD45R+), CD3
CD8+ CD4 T cells, CD4+ CD25+ Foxp3+ Treg cells,
and adipocytes (Ad). n = 8 preparations, each
from 5 mice. *p < 0.05.
(E) B cells, F4/80+ CD11b+ macrophages (Mac),
and adipocytes (Ad) from epididymal and inguinal
s.c. adipose tissue and B cells from spleen were
isolated from 20-week-old lean mice and cultured
for 48 hr at a density of 5 3 104 cells/ml in
Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS)
without LPS stimulation. IL-10 levels in the culture
media were then analyzed using a multianalyte
profiling system. n = 8 preparations, each from
5 mice.
(F) Flow cytometric analysis of IgM, IgD, CD1d,
and CD5 expression on CD19+ CD22+ CD45R+ B
cells from adipose tissue, spleen, and peritoneum
from 20-week-old ND mice. B-1 (CD19+ CD22+
CD45Rlow) and B-2 (CD19+ CD22+ CD45Rhigh)
cells were identified among the peritoneal cells.
n = 5 for each medium.
We expressed the results as means ± SEM. See
also Figure S1.
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Using flow cytometric analyses, we found that in lean C57BL/6
mice, approximately 30% of stromal vascular (SV) cells in the
inguinal subcutaneous (s.c.) adipose tissue and 7%–10% of
SV cells in the epididymal, retroperitoneal, and omental visceral
adipose tissue are CD19+ CD22+ CD45R+ mature B cells (Fig-
ures 1A and S1A, available online). Notably, the majority of
freshly isolated, unstimulated adipose B cells contained high
levels of IL-10 in their cytoplasm (Figures 1B and S1B), and the
IL-10 levels were higher in s.c. than in epididymal B cells. By760 Cell Metabolism 18, 759–766, November 5, 2013 ª2013 Elseviercontrast, splenic B cells did not express IL-10 under basal con-
ditions (Yanaba et al., 2008), nor did B cells from bone marrow
(BM), peripheral blood, liver, or skeletal muscle (Figure 1B and
data not shown). It was previously reported that M2 macro-
phages and Treg cells produce IL-10. However, the levels of
Il10 mRNA expression and of intracellular IL-10 were clearly
much lower in those cell types than in B cells in both s.c. and
epididymal adipose tissue (Figures 1C and 1D). Moreover,
when cultured, adipose B cells secreted IL-10 in the absence
of lipopolysaccharide (LPS) stimulation (Figure 1E). This is in
contrast to previously identified B cells, which expressed IL-10Inc.
Figure 2. IL-10 Produced by B Cells Is a
Critical Regulator of Adipose Tissue Inflam-
mation
To generate B cell-specific, Il10-deficientmice, we
transplanted BM mixtures composed of 10%
Il10/ and 90% B cell-deficient (IL10KO + BKO);
10% wild-type; and 90% BKO (WT + BKO), 100%
BKO, or 100% WT (WT to WT) cells into 4-week-
old wild-type mice, which were then fed a normal
chowdiet for 4weeks. Then, beginning at 8weeks,
the mice were fed either normal chow or a HFD for
an additional 11 weeks.
(A) Flow cytometric analysis of CD19+ CD22+
CD45R+ B cells, CD8+ T cells (CD3+ CD4 CD8+),
and CD4+ T cells (CD3+ CD4+ CD8) and M1 (F4/
80+ CD11c+ CD206) macrophages in epididymal
and s.c. adipose tissue. n = 5 animals in each
group. The number of each cell type was normal-
ized to the total number of viable (PI) cells in the
SVF. Mice were fed with either ND or HFD (DIO).
*p < 0.05. #p < 0.05 versusWT toWT. Results from
unmanipulated WT mice similarly fed a ND or HFD
are shown as references (WT). These mice were
not used in the statistical analyses.
(B) Real-time PCR analysis of cytokine gene
expression in epididymal and s.c. adipose tissue.
The levels of each transcript were normalized to
those in epididymal adipose tissue fromWT to WT
mice fed a normal diet (ND). n = 8 animals in each
group. *p < 0.05.
(C and D) Results of insulin (1 U/kg, after 3.5 hr
fasting) (C) and oral glucose (1 g/kg, after 16 hr
fasting) (D) tolerance tests. n = 10 animals in each
group. *p < 0.05 for BKO versus WT to WT on the
same diet, #p < 0.05 IL10KO + BKO versus WT to
WT on the same diet.
(E) CD44 and IFN-g production in CD8+ T cells
within epididymal fat pads the chimeric mice.
Shown are relative mean fluorescent intensities
(MFI). n = 8 preparations, each from 5 mice. *p <
0.05. We expressed the results as means ± SEM.
See also Figure S2.
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level of IL-10 secretion from adipose tissue B cells was higher
than from other cell types, including macrophages, T cells, and
adipocytes (Figure 1E). Taken together, these results indicate
that B cells are the major cell type expressing IL-10 in adipose
tissue.
Splenic B10 cells are known to be CD1dhigh CD5+, but adipose
IL-10+ B cells were CD1dlow CD5–/low (Figure 1F). The surface
phenotypes of adipose IL-10+ B cells also differed from those
of splenic and peritoneal B-1a cells, due to the low levels of
CD5 and CD23 expression (Figures 1F and S1C). Likewise, the
surface characteristics of adipose IL-10+ B cells differed from
other regulatory B cell subsets, including CD1dhigh CD21highCell Metabolism 18, 759–766,CD23 IgMhigh IgD MZ B cells and
CD1dhigh CD21high CD23+ IgMhigh IgD
T2 MZ precursor B cells (Mizoguchi
et al., 2002; Srivastava et al., 2005)(Fig-
ure S1C). Collectively then, adipose
IL-10+ B cells from epididymal and s.c.adipose tissue are CD1dlow CD5–/low CD11blow CD21/CD35low
CD23/low CD25+ CD69+ CD72high CD185 CD196+ IgM+ IgD+,
which is distinct from any other known IL-10-producing B cells.
We next hypothesized that adipose tissue IL-10+ B cells nega-
tively regulate the adipose tissue inflammation via IL-10 produc-
tion. To test that hypothesis, we generated BM chimeric mice in
which Il10 was selectively deleted from B cells (Figures 2 and
S2). Mixtures of 10% Il10/ BM and 90% B cell-deficient BM
(IL10KO + BKO), 10% wild-type (WT) and 90% BKO BM (WT +
BKO), or 100% WT BM (WT to WT) and BKO BM (BKO) were
transplanted into WT mice. Chimerism analyses showed that
while the majority (approximately 90%) of Treg cells and macro-
phages were derived from BKO BM, all B cells were derivedNovember 5, 2013 ª2013 Elsevier Inc. 761
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mice (Figure S2A). IL-10 production was not observed in B cells
from IL10KO + BKO chimeric mice (Figure S2B). All the mice
were then fed either a HFD or normal diet. There were no differ-
ences in body weight gains or fat pad weights among the three
types of chimeric mice (Figures S2C and S2D). B cell-specific
Il10 deletion (IL10 + BKO) increased the CD8+ T cell and M1
macrophage fractions in s.c. and epididymal adipose tissues
from diet-induced obese (DIO) mice and in s.c. adipose tissue
from lean mice (Figures 2A and S2E). In addition, levels of Tnf,
Ccl2, and Il6 expression were significantly higher in adipose tis-
sue from IL10KO + BKOmice than in the control WT toWTmice,
while IL-10 levels were much reduced, as expected (Figure 2B).
These results clearly demonstrate that IL-10 produced by B cells
within adipose tissue is crucial for suppression of inflammatory
activation andmaintenance of tissue homeostasis. As compared
to the control WT to WT chimeric mice, B cell-specific Il10-defi-
cient (IL10 + BKO) and B cell-deficient (BKO) chimeric mice fed a
normal diet showed modest insulin resistance and glucose intol-
erance, and thosemetabolic abnormalities were aggravated by a
HFD (Figures 2C and 2D). Thus, production of IL-10 by B cells
appears to be important for suppressing insulin resistance,
even under physiological conditions. The observation that
IL-10+ B cells negatively regulate inflammation and maintain
homeostasis within adipose tissue indicates that the IL-10+ B
cells function as regulatory B cells.
CD8+ T cell activation is one of the earliest events in the inflam-
matory processes seen during the development of obesity and is
followed by M1 macrophage activation (Nishimura et al., 2009).
We therefore hypothesized that Breg cells may continuously sup-
press activation of CD8+ T cells. Supporting our hypothesis was
the observation that B cell-specific Il10 deletion increased levels
of CD44 and interferon gamma (IFN-g) expression in CD8+ T cells
in epididymal and s.c. fat pads (Figures 2E and S2F).
To further test whether adipose Breg cells are capable of inhib-
iting CD8+ T cells locally within adipose tissue, we transplanted
adipose B cells isolated from the s.c. fat pads of lean wild-type
mice or splenic B cells into s.c. inguinal fat pads of obese BKO
mice. The transplantation of adipose B cells reduced the levels
of CD44 and IFN-g expression in CD8+ T cells, as well as levels
of tumor necrosis factor alpha (TNF-a) in macrophages in the
ipsilateral fat pads (Figures 3A and 3B), but this effect was not
observed after splenic B cell transplantation. In addition, IFN-g
secretion from CD8+ T cells was suppressed by the adipose B
cell transplantation (Figure S3A). Importantly, adipose B cell
transplantation did not affect CD8+ T cell activation in the contra-
lateral inguinal fat pads. Moreover, transplanting Il10/ adipose
tissue B cells or wild-type splenic B cells failed to inhibit CD8+
T cell activation (Figures 3A and S3A).
We then tested whether Breg cells might directly suppress
CD8+ T cells. Coculturing CD8+ T cells isolated from obese s.c.
adipose tissue with adipose B cells isolated from lean s.c. and
epididymal adipose tissue suppressed levels of CD44 and
IFN-g expression in CD8+ T cells, and this suppressive effect
was eliminated by anti-iL-10 neutralizing antibody (Figure 3C).
Similarly, s.c. adipose B cells suppressed IFN-g secretion from
CD8+ T cells in an IL-10-dependent manner (Figure S3B). In
line with those results, IL-10 suppressed expression of CD44
and IFN-g and secretion of IFN-g in cultured adipose CD8+762 Cell Metabolism 18, 759–766, November 5, 2013 ª2013 ElsevierT cells (Figures S3C and S3D). These findings support the notion
that adipose Breg cells locally suppress activation of CD8
+ T cells
via IL-10 and that adipose Breg cells play a pivotal role in the
maintenance of adipose homeostasis by restraining CD8+
T cells.
To further assess the functional role of Breg cells in suppress-
ing adipose tissue inflammation and in systemic metabolism, we
adoptively transferred B cells to DIO mice. The initial experi-
ments showed that adoptively transferred adipose tissue B cells
efficiently accumulated in the adipose tissue, whereas B cells
from the spleen and peritoneal cavity did not (Figure S3E).
Thus, systemic injection could be used to transfer adipose B
cells to fat depots, indicating that a mechanism exists to recruit
adipose B cells to fat depots. We then transferred 5 3 105 adi-
pose B cells to DIO mice 3 times each week for 2 weeks. Adop-
tive transfer of s.c. adipose tissue B cells from lean wild-type
mice reduced CD44 and IFN-g expression in CD8+ T cells in
both epididymal and s.c. adipose tissue (Figure 3D) and
improved insulin sensitivity (Figure 3E). Notably, adoptive trans-
fer of s.c. adipose B cells also suppressed inflammatory cytokine
expression (Tnf and Ccl2) in both s.c. and epididymal fat pads
(Figure 3F). Those effects were diminished when adipose B cells
from DIOmice were transferred (Figures 3D–3F). In addition, s.c.
adipose tissue B cells from IL-10 KO mice did not induce those
effects (Figures 3D–3F). These results further support the notion
that adipose Breg cells negatively regulate inflammation in obese
adipose tissue at least in part via IL-10 production. The results
also highlight the functional difference between adipose tissue
Breg cells and splenic B cells.
In contrast to adipose Breg cells, other regulatory B cells do not
constitutively express IL-10 under physiological conditions. We
therefore hypothesized that the adipose microenvironment sup-
ports the unique characteristics of adipose Breg cells. Consistent
with that idea, coculturing B cells with s.c. adipose tissue
increased B cell production and secretion of IL-10 (Figures 4A
and S4A). Coculture with fat pad also improved the survival
rate among adipose B cells (Figure S4B). These results suggest
the presence in adipose tissue of humoral factors that support
Breg cell IL-10 production and survival. Several signals have
been shown to prime Breg function and IL-10 secretion, including
signaling in the Toll-like receptor 4 (TLR4) pathways (Yanaba
et al., 2008). We therefore first tested the effects of LPS and
found that LPS increased intracellular IL-10 and its secretion in
both s.c. and epididymal adipose B cells (Figures 4B and S4C).
On the other hand, even when treated with LPS, the amount of
IL-10 secreted from splenic B cells was much smaller than that
secreted from unstimulated adipose B cells. LPS also increased
the viability of all B cell preparations (Figure S4D). As would be
expected from these findings, pretreating s.c. and epididymal
adipose B cells with LPS enhanced their suppressive effect on
CD8+ T cells (Figure S4E).
Previous studies have shown that saturated free fatty acids
(FFAs), which are released from adipocytes through lipolysis of
stored triglycerides, can activate TLR4 signaling (Eguchi et al.,
2012). We therefore tested whether saturated FFAs directly
affect adipose B cells and found that palmitate improved survival
among cultured adipose B cells, but not splenic B cells, and
induced IL-10 production in adipose B cells (Figures 4C and
S4F). This suggests that the local factors within adipose tissueInc.
Figure 3. Adoptively Transferred Adipose B
Cells Suppress Adipose Inflammation in
DIO Mice
(A and B) B cells were obtained from inguinal ad-
ipose tissue and spleen from 20-week-old lean
wild-type and IL-10 knockout mice. Isolated cells
(5 3 105 per mouse) were injected locally into
inguinal fat pads of 25-week-old obese BKOmice,
and 2 days later we assessed CD8+ T cell (A) and
macrophage (B) activation in the treated ipsilateral
(Ipsi) and contralateral (Contra) fat pads trans-
planted with wild-type adipose B cells and ipsi-
lateral fat pads transplanted with splenic B cells
(Spl) and adipose B cells from IL-10 KO mice
(IL10KO). Subcutaneous adipose tissue of un-
treated age-matched DIO mice was used as a
control (CTRL). Shown are relative MFIs. n = 5
preparations, each from 5 mice. *p < 0.05.
(C) CD8+ T cells from s.c. fat pads collected from
obese mice were cocultured with CD19+ CD45R+
B cells from s.c. (+SCB) and epididymal (+epiB) fat
pads collected from lean mice or s.c. B cells plus
anti-iL-10 neutralizing antibody (10 mg/ml) (+SCB +
IL10Ab). The phenotypes of the CD8+ T cells were
analyzed after 48 hr. CD8+ T cells cultured alone
served as a control (CTRL). n = 5 preparations,
each from 5 mice.
(D–F) B cells were isolated from s.c. fat pad from
25-week-old lean (+ND B) and obese (+DIO B) WT
mice and lean IL-10 KO mice (+IL10KO B) as well
as from splenic B cells from WT mice (+spl B).
Thereafter, 24-week-old WT DIO mice were
intravenously administered 5 3 105 cells per
mouse three times each week. After administra-
tion for 2 weeks, insulin tolerance test (ITT) ex-
periments and flow cytometric analysis of s.c. fat
pads were performed. We compared adoptively
transferredmicewith vehicle-treatedWTDIOmice
serving as a control (DIO). In (D), CD44 and IFN-g
expression in CD8+ T cells within epididymal and
s.c. adipose tissues was analyzed. n = 8 mice. In
(E), results of ITTs (1 U/kg, after 3.5 hr fasting) are
shown. n = 10 animals in each group. *p < 0.05 for DIO versus +ND B; yp < 0.05 for +ND B cell versus +DIO B cell. (F) shows real-time PCR analysis of cytokine
gene expression in epididymal and s.c. adipose tissue. The levels of each transcript were normalized to those in adipose tissue from control DIO mice. n = 8
animals in each group; *p < 0.05. We expressed the results as means ± SEM. See also Figure S3.
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unique functions of adipose Breg cells.
To further identify the microenvironmental factors supporting
adipose Breg cells, we used PCR arrays to systematically
analyze the gene expression of cytokine and chemokine recep-
tors. This analysis revealed that two receptor genes, Il10ra and
Cxcr4, were expressed more strongly in adipose than in splenic
B cells (Figure 4D). We then assessed the effects of the ligands
for those receptors. We found that IL-10 itself increased levels
of intracellular IL-10 and its secretion from both s.c. and epidid-
ymal adipose B cells, but not splenic B cells (Figures 4B and
S4C). IL-10 also improved the viability of adipose B cells, but
not splenic B cells (Figure S4D). Moreover, addition of an anti-
IL-10 neutralizing antibody partially inhibited the prosurvival
effect of adipose tissue on adipose B cell viability (Figure S4B),
and pretreating adipose B cells with IL-10 augmented their sup-
pressive effects on CD8+ T cells (Figure S4E). These results
show that IL-10 enhances adipose B cell survival and function
in vitro.Cell MInhibition of IL-10 signaling through systemic administration of
an anti-IL-10 neutralizing antibody modestly, but significantly,
reduced the B cell fraction in adipose tissue, but not in bone
marrow, spleen, liver, or skeletal muscle (Figures S4G and
S4H). As expected, IL-10 neutralization also increased CD44
and IFN-g expression in adipose CD8+ T cells (Figure S4I).
Genetic Il10 deletion reduced B cell numbers in fat pads, but
not in bonemarrow, spleen, liver, or skeletal muscle (Figure S4J).
These results suggest that IL-10 is one of the environmental fac-
tors present in adipose tissue, though the presence of B cells in
the adipose tissue of IL-10 knockout mice suggests that other
factors are also involved.
We next analyzed the C-X-C chemokine receptor type 4
(CXCR4) ligand CXCL12. Cxcl12 was expressed in SV cells
within all the adipose tissues analyzed (i.e., inguinal, epididymal,
omental, and retroperitoneal fat), and its expression levels were
higher in adipose SV cells than in spleen (Figure 4E and data not
shown), suggesting that CXCL12might contribute to B cell accu-
mulation in adipose tissue. To test this idea, we locally injectedetabolism 18, 759–766, November 5, 2013 ª2013 Elsevier Inc. 763
Figure 4. Environmental Factors within
Adipose Tissue Support Breg Cell Survival
and Function
(A) B cells were incubated for 48 hr in the presence
of pieces of s.c. adipose tissue from WT (+WTfat),
IL-10 knockout (+IL10KOfat), or BKO (+BKOfat),
after which their IL-10 production was analyzed.
n = 5 experiments in each group.
(B) Intracellular production of IL-10 in B cells after
incubation for 48 hr with LPS (1 mg/ml) or recom-
binant IL-10 (10 ng/ml). n = 5 preparations, each
from 5 mice.
(C) Cultured B cells isolated from spleen and
epididymal and s.c. fat pads from 20-week-old
lean mice were treated for 48 hr with vehicle
(CTRL), palmitate (PA; 100 mM), or recombinant
CXCL12 (10 ng/ml), after which intracellular IL-
10 production was analyzed. Neutralizing anti-
CXCL12 antibody (10 mg/ml) was also added
to some cells treated with palmitate and
CXCL12 (+CXCL12Ab). n = 5 experiments in each
group.
(D) Expression of Il10ra and Cxcr4 in B cells in
spleen and epididymal or s.c. fat pad from lean
mice. n = 5 animals in each group.
(E) Expression of Cxcl12 (SDF-1, CXCR4 ligand) in
the SV fractions of s.c. and epididymal adipose
tissues, and spleen from 25-week-old lean and
DIO mice. n = 5 animals.
(F and G) Mice were fed a HFD for 21 weeks,
beginning when they were 4 weeks old, and were
administered CXCL12 (0.5 mg per g body weight)
into an inguinal fat pad daily for 2 weeks. Age-
matched obese mice served as controls (CTRL).
In (F), the relative B cell fractions in the treated
ipsilateral (Ipsi) or contralateral (Contra) fat pads
are shown. In (G), intracellular IL-10 in B cells in
s.c. fat pads is shown. n = 5 experiments in each
group; *p < 0.05.
(H) Flow cytometric analysis of immune cells in
epididymal and s.c. fat pads from lean mice fed a
normal chow diet (ND); diet-induced-obese (DIO)
mice fed a HFD for 16 weeks, beginning when
they were 4 weeks old; and ob/ob mice fed a ND.
All mice were analyzed when they were 20 weeks
old. The number of each cell type was normalized
to the total number of viable (PI) cells in the SVF,
and fractions among viable cells are shown. The
total number of each cell type per fat depot is
shown in Figure S4L. n = 5 animals in each group.
*p < 0.05.
(I) Intracellular IL-10 in B cells isolated from
mouse s.c. adipose tissue at the indicated ages.
The DIO mice were fed a HFD, beginning when
the mice were 4 weeks old. *p < 0.05 versus
4 weeks old.
(J) Fractions of early apoptotic (Annexin V+ PI)
cells among B cells in s.c. adipose tissue from
25-week-old DIO mice. n = 5 animals.
(K) B cells (2 3 105 cells per g body weight)
obtained from inguinal adipose tissue were
adoptively transferred into 25-week-old lean and DIO mice. Shown is the total number of transferred B cells detected within each s.c. fat pad. n = 5 animals
in each group.
(L) Levels of gene expression in the SV fractions of s.c. fat pads obtained at surgery from human subjects and body mass index values were analyzed. R values
were calculated using Pearson’s correlation coefficient test. Expression levels were normalized to the average of all subjects. n = 20 subjects.
(M) Schematic model of B cell function in adipose homeostasis and inflammation. We expressed the results as means ± SEM. See also Figure S4.
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Adipose Breg Cells Control InflammationCXCL12 into s.c. inguinal fat pads of DIO mice. Local CXCL12
selectively increased the B cell fractions in the injected fat
pads without affecting T cell or macrophage fractions (Figure 4F
and data not shown). By contrast, the injection did not affect B
cell fractions in the contralateral inguinal fat pads, which sup-
ports the notion that CXCL12 affects B cell accumulation locally
within the injected fat pads. CXCL12 injection also increased IL-
10 production in B cells (Figure 4G). Consistent with that obser-
vation, IL-10 production was enhanced in B cells isolated from
adipose tissue treated with CXCL12 ex vivo but was unaffected
in splenic B cells treated likewise (Figure 4C).
Notably, addition of palmitate further activated IL-10 produc-
tion in adipose B cells treated with CXCL12, and this additive
effect was blocked by an anti-CXCL12 neutralizing antibody
(Figure 4C), suggesting that there is crosstalk between CXCR4
and TLR4 signaling. To test that idea, B cells were treated with
palmitate and/or CXCL12 in the presence of a kinase inhibitor.
We found that both BMS345541 (IkB kinase [IKK] inhibitor) and
LY294002 (PI3K inhibitor) partially suppressed the activation of
IL-10 production by palmitate and CXCL12 and reduced B
cell survival (Figure S4K and data not shown). By contrast,
PD98059 (MEK1 inhibitor) had no significant effects. These re-
sults suggest that both the NF-kB and PI3K/Akt pathways are
important for the activation of Breg cell function by CXCL12
and FFA. However, further studies are needed to elucidate the
signaling crosstalk underlying the combinatorial activation of
Breg cells. Collectively, these findings demonstrate that multiple
environmental mediators and saturated FFAs act cooperatively
to support adipose Breg cells.
The results so far demonstrate that adipose Breg cells restrain
adipose tissue inflammation. We then asked what is the role of
Breg cells during the progression of adipose tissue inflammation?
In both s.c. and visceral adipose tissue, the B cell fractions were
significantly smaller in DIO mice fed a HFD for 16 weeks than in
lean controls (Figures 4H and S4L). Similarly, B cell fractions
were smaller in ob/ob mice than in lean wild-type mice. In
contrast to adipose tissue, B cell fractions in BM, spleen, and
peripheral blood were unaffected by a HFD (data not shown).
Moreover, IL-10 expression in B cells was progressively dimin-
ished in adipose tissue by DIO (Figure 4I), and the suppressive
effect of Breg cells isolated from obese adipose tissue on CD8
+
T cell activation was compromised, as compared to Breg cells
from lean adipose tissue (Figure 3D).
The smaller B cell fractionmay be explained, at least in part, by
the reduction in Cxcl12 and Il10 expression (Figures 4E and
S4M), which could affect B cell accumulation, activation, and
survival. Consistent with that idea, we found that the incidence
of apoptotic B cells was increased in obese adipose tissue (Fig-
ure 4J) and that adoptively transferred adipose B cells were less
efficiently accumulated in obese adipose tissue (Figure 4K).
Taken together, these findings suggest that adipose tissue
obesity alters environmental cues (i.e., CXCL12 and IL-10)
important for B cell recruitment, survival, and activation, and
the resultant Breg cell dysfunction contributes to the progression
of adipose tissue inflammation.
To gain insight into the clinical significance of adipose B cells
in humans, we analyzed the expression levels of several cyto-
kines (TNF, CCL2, IL10, CXCL12, and MIF) as well as markers
of B cells (CD19 and CD22) and macrophages (EMR1) in theCell MSV fraction from human subcutaneous adipose tissues (Figures
4L and S4N). We found that levels of B cell markers and IL10
inversely correlated with body mass index (BMI), suggesting
that the B cell fraction is reduced in obese subcutaneous adi-
pose tissue. Levels of CXCL12 expression were also reduced
in obese subjects. By contrast, levels of EMR1, CCL2, and
TNF were positively associated with BMI but were inversely
correlated with B cell markers and IL10. Finally, B cells isolated
from human subcutaneous adipose tissue produced IL-10
(Figure S4O). Collectively, these results strongly suggest that
adipose B cells are an important regulator of inflammation in
adipose tissue and that B cell dysfunction contributes to the
progression of adipose inflammation in humans.
In the present study, we showed that adipose tissue contains
large numbers of Breg cells, which we will define as adipose nat-
ural regulatoryBcells. SplenicBreg activities require activation via
TLR4 signaling, CD40, B cell receptor, and/or TLR9 for IL-10 pro-
duction (Vitale et al., 2010), but adipose Breg cells secrete IL-10
constitutively, without additional activation of these signals.
Those results, along with our surface marker analysis, suggest
that adipose Breg cells are a functionally unique B cell subset.
Our results also support amodel in which adipose natural regula-
tory B cells restrain inflammatory activation by suppressingCD8+
T cells at least in part via IL-10 production, even under physiolog-
ical conditions. In this way, natural regulatory B cells maintain
local homeostasis within adipose tissue as well as systemic
metabolic homeostasis (Figure 4M). Although adipose Breg cells
continuously produce IL-10, Breg cell fractions and IL-10 produc-
tion are progressively diminished in obese adipose tissue, which
further promotes development of inflammation.
Breg cells were present within all the fat depots analyzed, and
the microenvironmental factors supporting Breg cells, such as
CXCL12, were also expressed in those depots. However, the
size of Breg cell population differed among fat depots and was
largest in s.c. fat. The large population of Breg cells in s.c. fat
may contribute to the fact that this tissue is more protected
from HFD-induced inflammation than visceral fat tissues. That
said, our results clearly demonstrate that Breg cells play an
essential regulatory role in both visceral and s.c. adipose tissue.
Indeed, Breg cells in both fat depots constitutively produce IL-10
and are capable of suppressing CD8+ T cells, as evidenced by
our finding that B cell-specific Il10 deletion aggravated inflam-
mation in both visceral and s.c. adipose tissue, as well as insulin
intolerance induced by HFD (Figure 2).
Winer et al. (2011) recently reported that B cells promote adi-
pose inflammation and insulin resistance, possibly by secreting
IgG (auto)antibodies. This suggests that B cells may assume
dual roles within adipose tissue. In the present study, we were
unable to detect either IgG secretion from adipose B cells or
IgG class switching in major B cell populations (data not shown).
The reasons for this discrepancy are not immediately clear. How-
ever, we found that both the number of adipose tissue Breg cells
and the IL-10 production were higher in adipose B cells in germ-
free mice than specific pathogen-free (SPF) mice (data not
shown). It is tempting to speculate that endogenous and envi-
ronmental factors affect adipose B cell phenotypes.
In conclusion, we have identified adipose natural regulatory B
cells, which are crucial for maintaining homeostasis within adi-
pose tissue. Our results suggest that controlling adipose naturaletabolism 18, 759–766, November 5, 2013 ª2013 Elsevier Inc. 765
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Adipose Breg Cells Control Inflammationregulatory B cell function could serve as the basis for novel
approaches to the treatment of metabolic syndrome and other
obesity-related diseases.
EXPERIMENTAL PROCEDURES
Animals
B cell-deficient mice were described previously (Kitamura et al., 1991). Full
methods and any associated references are available in the Supplemental
Information. All experiments were approved by the University of Tokyo Ethics
Committee for Animal Experiments and strictly adhered to the guidelines for
animal experiments of the University of Tokyo.
Human Subjects
After obtaining informed consent using an institutional review board-approved
protocol, we acquired subcutaneous adipose tissue from healthy female
donors undergoing liposuction of the abdomen or thighs.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cmet.2013.09.017.
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